On 2026-10-22, Wells Fargo raised its ABT price target to $119 from $112 (+6.2%).
Wells Fargo 于 2026-10-22 将 ABT 目标价上调至 $119，此前为 $112，变动幅度 +6.2%。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
Barclays initiates coverage of ABT with OverweightBarclays 首次覆盖 雅培 (ABT)，初始评级 增持（Overweight）
Rating Change · October 6, 2026评级变动 · 2026/10/6
ABT receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart conditionAbbott Laboratories（ABT）的 new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition 获美国 FDA 批准
Material Company Event · October 5, 2026公司公告 · 2026/10/5
ABT receives FDA approval for TactiFlex™ Duo Ablation CatheterAbbott Laboratories（ABT）的 TactiFlex™ Duo 消融导管 获美国 FDA 批准
Material Company Event · September 8, 2026公司公告 · 2026/9/8
